The document is a response from the FDA regarding the notification submitted by BD Botanicals Ltd. for a new dietary ingredient known as “Mitragyna speciosa strain XML007,” marketed as “Kratura™.”
Link: https://kri.org/wp-content/uploads/2024/10/NDI-1126-Original-Notification.pdf
Link: https://kri.org/wp-content/uploads/2024/10/NDI-1126-FDA-Response.pdf
The Kratom Research Institute was established to create a trusted hub for kratom-related information. We are a non-partisan organization focused solely on delivering facts, studies, and news, without promoting or opposing the use of kratom. Our goal is to offer a clear, objective view of the current state of kratom research, regulations, and public discourse.
We understand that kratom is a topic of debate, and that’s why we take a balanced approach—presenting information from all sides so you can make informed decisions based on credible sources.
